MET and hepatocellular carcinoma: Several tyrosine-kinase receptors, including vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and the scatter growth factor receptor MET, have been implicated in the proliferation and invasion of HCC.